dc.contributor.author | Karaman, E. | |
dc.contributor.author | Seven, D. | |
dc.contributor.author | Dogan, S. | |
dc.contributor.author | Gozen, E. D. | |
dc.contributor.author | Ulker, D. | |
dc.contributor.author | Buyru, N. | |
dc.contributor.author | Ekizoglu, S. | |
dc.date.accessioned | 2021-03-05T13:56:22Z | |
dc.date.available | 2021-03-05T13:56:22Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Ekizoglu S., Dogan S., Ulker D., Seven D., Gozen E. D. , Karaman E., Buyru N., "The effect of LKB1 on the PI3K/Akt pathway activation in association with PTEN and PIK3CA in HNC", CLINICAL OTOLARYNGOLOGY, cilt.40, ss.622-628, 2015 | |
dc.identifier.issn | 1749-4478 | |
dc.identifier.other | av_b4a5f1fc-b9a3-4e34-ada0-1a7bb3c95a2f | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/120296 | |
dc.identifier.uri | https://doi.org/10.1111/coa.12427 | |
dc.description.abstract | Objective: PI3K/Akt signalling pathway is frequently activated in several types of cancer. However, activator molecules have not been analysed systematically in HNSCC. The aim of this study was to investigate upstream activators and inhibitors of this pathway. | |
dc.language.iso | eng | |
dc.subject | Klinik Tıp | |
dc.subject | KULAK BURUN BOĞAZ | |
dc.subject | Kulak Burun Boğaz | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.title | The effect of LKB1 on the PI3K/Akt pathway activation in association with PTEN and PIK3CA in HNC | |
dc.type | Makale | |
dc.relation.journal | CLINICAL OTOLARYNGOLOGY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 40 | |
dc.identifier.issue | 6 | |
dc.identifier.startpage | 622 | |
dc.identifier.endpage | 628 | |
dc.contributor.firstauthorID | 226550 | |